Erythrocyte Disorders in the Perinatal Period

Seminars in Perinatology

Volumn 31, Issue 4, 2007, Pages 254-261

  Steiner, Laurie A ^a   Gallagher, Patrick G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anemia; erythrocyte; genetic; hydrops fetalis; neonatal

Indexed keywords

ANDROGEN; BETA GLOBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; HEMOGLOBIN H; OXYMETHOLONE; PYRUVATE KINASE; STEROID;

BLACKFAN DIAMOND ANEMIA; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CONGENITAL DYSERYTHROPOIETIC ANEMIA; DISEASE ASSOCIATION; ELLIPTOCYTOSIS; ENZYME DEFICIENCY; ERYTHROCYTE DISORDER; ERYTHROCYTE METABOLISM; ERYTHROPOIESIS; FANCONI ANEMIA; FETUS HYDROPS; GENE DELETION; GENE MUTATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMATOLOGIC DISEASE; HEMOGLOBINOPATHY; HEREDITARY PYROPOIKILOCYTOSIS; HEREDITARY SPHEROCYTOSIS; HUMAN; MORBIDITY; MORTALITY; NEWBORN ANEMIA; PEARSON SYNDROME; PERINATAL PERIOD; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SHWACHMAN SYNDROME; STOMATOCYTOSIS;

ANEMIA; ERYTHROCYTES; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMATOLOGIC DISEASES; HEMOGLOBINOPATHIES; HUMANS; INFANT, NEWBORN; PYRUVATE KINASE;

EID: 34548305265     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2007.05.003     Document Type: Review

References (90)

1. In: Handin R.I., Lux S.E., and Stossel T.P. (Eds). Blood. Principles and Practices of Hematology (2003), Lippincott, Philadelphia, PA
2. Forestier F., Daffos F., Catherine N., et al. Developmental hematopoiesis in normal human fetal blood. Blood 77 (1991) 2360-2363
3. Zipurksy A., Brown E., Palko J., et al. The erythrocyte differential in newborn infants. Am J Pediatr Hematol Oncol 5 (1983) 45-51
4. In: Christensen R.D. (Ed). Hematologic Problems of the Neonate (2000), WB Saunders, Philadelphia, PA
5. Holroyde C.P., Oski F.A., and Gardner F.H. The "pocked" erythrocyte. Red-cell surface alterations in reticuloendothelial immaturity of the neonate. N Engl J Med 281 (1969) 516-520
6. Pearson H.A. Life-span of the fetal red blood cell. J Pediatr 70 (1967) 166-171
7. Kleihauer E., Braun H., and Betke K. Demonstration of fetal hemoglobin in erythrocytes of a blood smear. Klin Wochenschr 35 (1957) 637-638
8. Gross R.T., Bracci R., Rudolph N., et al. Hydrogen peroxide toxicity and detoxification in the erythrocytes of newborn infants. Blood 29 (1967) 481-493
9. Luzzatto L. Genetics of red cells and susceptibility to malaria. Blood 54 (1979) 961-976
10. Higgs D.R., Vickers M.A., Wilkie A.O., et al. A review of the molecular genetics of the human alpha-globin gene cluster. Blood 73 (1989) 1081-1104
11. Chan V., Chan T.K., Liang S.T., et al. Hydrops fetalis due to an unusual form of Hb H disease. Blood 66 (1985) 224-228
12. Ko T.M., Hseih F.J., Hsu P.M., et al. Molecular characterization of severe alpha-thalassemias causing hydrops fetalis in Taiwan. Am J Med Genet 39 (1991) 317-320
13. Chan V., Chan V.W., Tang M., et al. Molecular defects in Hb H hydrops fetalis. Br J Haematol 96 (1997) 224-228
14. Ne-Win, Harano K., Harano T., et al. Common alpha-thalassemia deletions in transfusion-dependent thalassemia patients in the Southeast Asia region of Myanmar. Lab Hematol 12 (2006) 139-142
15. Chui D.H., and Waye J.S. Hydrops fetalis caused by alpha-thalassemia: an emerging healthcare problem. Blood 91 (1998) 2213-2222
16. Hofstaetter C., Gonser M., and Goelz R. Perinatal case report of unexpected thalassemia Hb Bart. Fetal Diagn Ther 8 (1993) 418-422
17. Guy G., Coady D.J., Jansen V., et al. alpha-Thalassemia hydrops fetalis: clinical and ultrasonographic considerations. Am J Obstet Gynecol 153 (1985) 500-504
18. Liang S.T., Wong V.C., So W.W., et al. Homozygous alpha-thalassaemia: clinical presentation, diagnosis and management. A review of 46 cases. Br J Obstet Gynaecol 92 (1985) 680-684
19. Singer S.T., Styles L., Bojanowski J., et al. Changing outcome of homozygous alpha-thalassemia: cautious optimism. J Pediatr Hematol Oncol 22 (2000) 539-542
20. Pirastu M., Kan Y.W., Lin C.C., et al. Hemolytic disease of the newborn caused by a new deletion of the entire beta-globin cluster. J Clin Invest 72 (1983) 602-609
21. Orkin S.H., Goff S.C., and Nathan D.G. Heterogeneity of DNA deletion in gamma delta beta-Thalassemia. J Clin Invest 67 (1981) 878-884
22. Fortina P., Delgrosso K., Werner E., et al. A greater than 200 kb deletion removing the entire beta-like globin gene cluster in a family of Irish descent. Hemoglobin 15 (1991) 23-41
23. Driscoll M.C., Dobkin C.S., and Alter B.P. Gamma delta beta-Thalassemia due to a de novo mutation deleting the 5′ beta-globin gene activation-region hypersensitive sites. Proc Natl Acad Sci U S A 86 (1989) 7470-7474
24. Curtin P.T., and Kan Y.W. The inactive beta globin gene on a gamma delta beta thalassemia chromosome has a normal structure and functions normally in vitro. Blood 71 (1988) 766-770
25. Kan Y.W., Forget B.G., and Nathan D.G. Gamma-beta Thalassemia: a cause of hemolytic disease of the newborn. New Engl J Med 286 (1972) 129-134
26. Bollekens J.A., and Forget B.G. Delta beta thalassemia and hereditary persistence of fetal hemoglobin. Hematol Oncol Clin North Am 5 (1991) 399-422
27. In: Steinberg M.H., Forget B.G., Higgs D.R., et al. (Eds). Disorders of Hemoglobin. Genetics, Pathophysiology, and Clinical Management (2001), Cambridge University Press, Cambridge
28. Lee-Potter J.P., Deacon-Smith R.A., Simpkiss M.J., et al. A new cause of haemolytic anaemia in the newborn. A description of an unstable fetal haemoglobin: F Poole, alpha2-G-gamma2 130 trptophan yields glycine. J Clin Pathol 28 (1975) 317-320
29. 2): a hemoglobin found in low concentration. J Clin Invest 48 (1969) 834-847
30. Pissard S., Max-Audit I., Skopinski L., et al. Pyruvate kinase deficiency in France: a 3-year study reveals 27 new mutations. Br J Haematol 133 (2006) 683-689
31. Gilsanz F., Vega M.A., Gomez-Castillo E., et al. Fetal anemia due to pyruvate kinase deficiency. Arch Dis Child 69 (1993) 523-524
32. Hennekam R.C., Beemer F.A., Cats B.P., et al. Hydrops fetalis associated with red cell pyruvate kinase deficiency. Genet Couns 1 (1990) 75-79
33. Demina A., Varughese K.I., Barbot J., et al. Six previously undescribed pyruvate kinase mutations causing enzyme deficiency. Blood 92 (1998) 647-652
34. Zanella A., and Bianchi P. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations. Baillieres Best Pract Res Clin Haematol 13 (2000) 57-81
35. Diaz A., Gilsanz F., Martinez J., et al. Life-threatening nonspherocytic hemolytic anemia in a patient with a null mutation in the PKLR gene and no compensatory PKM gene expression. Blood 106 (2005) 1851-1856
36. Costa C., Albuisson J., Le T.H., et al. Severe hemolytic anemia in a Vietnamese family associated with novel mutations in the gene encoding for pyruvate kinase. Haematologica 90 (2005) 25-30
37. Bianchi P., and Zanella A. Hematologically important mutations: red cell pyruvate kinase. (Third Update). Blood Cells Mol Dis 26 (2000) 47-53
38. Lenzner C., Nurnberg P., Jacobasch G., et al. Molecular analysis of 29 pyruvate kinase-deficient patients from central Europe with hereditary hemolytic anemia. Blood 89 (1997) 1793-1799
39. Kanno H., Fujii H., Wei D.C., et al. Frame shift mutation, exon skipping, and a two codon deletion caused by splice site mutations account for pyruvate kinase deficiency. Blood 89 (1997) 4213-4218
40. van Wijk R., van Solinge W.W., Nerlov C., et al. Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency. Blood 101 (2003) 1596-1602
41. Suvatte V., Tanphaichitr V.S., Visuthisakchai S., et al. Bone marrow, peripheral blood and cord blood stem cell transplantation in children: ten years' experience at Siriraj Hospital. Int J Hematol 68 (1998) 411-419
42. Mehta A., Mason P.J., and Vulliamy T.J. Glucose-6-Phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol 13 (2000) 21-38
43. Ruwende C., Khoo S.C., Snow R.W., et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376 (1995) 246-249
44. Ursini M.V., Parrella A., Rosa G., et al. Enhanced expression of glucose-6-phosphate dehydrogenase in human cells sustaining oxidative stress. Biochem J 323 (1997) 801-806
45. Salvemini F., Franze A., Iervolino A., et al. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J Biol Chem 274 (1999) 2750-2757
46. Gaetani G.D., Parker J.C., and Kirkman H.N. Intracellular restraint: a new basis for the limitation in response to oxidative stress in human erythrocytes containing low-activity variants of glucose-6-phosphate dehydrogenase. Proc Natl Acad Sci U S A 71 (1974) 3584-3587
47. Perkins R.P. Hydrops fetalis and stillbirth in a male glucose-6-phosphate dehydrogenase-deficient fetus possibly due to maternal ingestion of sulfisoxazole; a case report. Am J Obstet Gynecol 111 (1971) 379-381
48. Mentzer W.C., and Collier E. Hydrops fetalis associated with erythrocyte G-6-PD deficiency and maternal ingestion of fava beans and ascorbic acid. J Pediatr 86 (1975) 565-567
49. Corchia C., Balata A., Meloni G.F., et al. Favism in a female newborn infant whose mother ingested fava beans before delivery. J Pediatr 127 (1995) 807-808
50. Kaplan M., Vreman H.J., Hammerman C., et al. Favism by proxy in nursing glucose-6-phosphate dehydrogenase-deficient neonates. J Perinatol 18 (1998) 477-479
51. Kaplan M., Leiter C., Hammerman C., et al. Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period. Clin Chem 43 (1997) 1236-1237
52. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 weeks or more of gestation. Pediatrics 114 (2004) 297-316
53. Eber S.W., Pekrun A., Neufeldt A., et al. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: screening using a modified glycerol lysis test. Ann Hematol 64 (1992) 88-92
54. Godal H.C., and Heisto H. High prevalence of increased osmotic fragility of red blood cells among Norwegian blood donors. Scand J Hematol 27 (1981) 30-34
55. Lux S., Tse W., Menninger J., et al. Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature 345 (1990) 736-739
56. Gallagher P.G. Update on the clinical spectrum and genetics of red blood cell membrane disorders. Curr Hematol Rep 3 (2004) 85-91
57. Gallagher P.G. Red cell membrane disorders. Hematol Am Soc Hematol Educ Prog (2005) 13-18
58. Whitfield C.F., Follweiler J.B., Lopresti-Morrow L., et al. Deficiency of α-spectrin synthesis in burst-forming units-erythroid in lethal hereditary spherocytosis. Blood 78 (1991) 3043-3051
59. Gallagher P.G., Weed S.A., Tse W.T., et al. Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene. J Clin Invest 95 (1995) 1174-1182
60. Gallagher P.G., Petruzzi M.J., Weed S.A., et al. Mutation of a highly conserved residue of beta spectrin associated with fatal and near-fatal neonatal hemolytic anemia. J Clin Invest 99 (1997) 267-277
61. Zarkowsky H.S., Mohandas N., Speaker C.B., et al. A congenital haemolytic anaemia with thermal sensitivity of the erythrocyte membrane. Br J Haematol 4 (1975) 537-543
62. MacDougall L.G., Moodley G., and Quirk M. The pyropoikilocytosis-elliptocytosis syndrome in a black South African infant: clinical and hematological features. Am J Pediatr Hematol Oncol 3 (1982) 344-349
63. Zhang Z., Weed S.A., Gallagher P.G., et al. Dynamic molecular modeling of pathogenic mutations in the spectrin self-association domain. Blood 98 (2001) 1645-1653
64. Delaunay J., Stewart G., and Iolascon A. Hereditary dehydrated and overhydrated stomatocytosis: recent advances. Curr Opin Hematol 6 (1999) 110-114
65. Grootenboer-Mignot S., Cretien A., Laurendeau I., et al. Sub-lethal hydrops as a manifestation of dehydrated hereditary stomatocytosis in two consecutive pregnancies. Prenat Diagn 23 (2003) 380-384
66. Vicente-Gutierrez M.P., Castello-Almazan I., Salvia-Roiges M.D., et al. Nonimmune hydrops fetalis due to congenital xerocytosis. J Perinatol 25 (2005) 63-65
67. Entezami M., Becker R., Menssen H.D., et al. Xerocytosis with concomitant intrauterine ascites: first description and therapeutic approach. Blood 87 (1996) 5392-5393
68. Sanchez M., Palacio M., Borrell A., et al. Prenatal diagnosis and management of fetal xerocytosis associated with ascites. Fetal Diagn Ther 20 (2005) 402-405
69. Grootenboer S., Schischmanoff P.O., Laurendeau I., et al. Pleiotropic syndrome of dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema maps to 16q23-q24. Blood 96 (2000) 2599-2605
70. Stewart G.W., Amess J.A., Eber S.W., et al. Thrombo-embolic disease after splenectomy for hereditary stomatocytosis. Br J Haematol 93 (1996) 303-310
71. Da Costa L., Willig T.N., Fixler J., et al. Diamond-Blackfan anemia. Curr Opin Pediatr 13 (2001) 10-15
72. Rogers B.B., Bloom S.L., and Buchanan G.R. Autosomal dominantly inherited Diamond-Blackfan anemia resulting in nonimmune hydrops. Obstet Gynecol 89 (1997) 805-807
73. Saladi S.M., Chattopadhyay T., and Adiotomre P.N. Nonimmune hydrops fetalis due to Diamond Blackfan anemia. Ind Pediatr 41 (2004) 187-188
74. Roy V., Perez W.S., Eapen M., et al. Non-malignant marrow disorders working committee of the International Bone Marrow Transplant Registry. Bone marrow transplantation for Diamond-Blackfan anemia. Biol Blood Marrow Transplant 11 (2005) 600-608
75. Makitie O., Ellis L., Durie P.R., et al. Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet 65 (2004) 101-112
76. Shwachman H., Diamond L.K., Oski F.A., et al. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 65 (1964) 645-663
77. Dror Y., and Freedman M.H. Shwachman-diamond syndrome. Br J Haematol 118 (2002) 701-713
78. Kato K., Sugitani M., Kawataki M., et al. Congenital dyserythropoietic anemia type 1 with fetal onset of severe anemia. J Pediatr Hematol Oncol 23 (2001) 63-66
79. Shalev H., Kapelushnik J., Moser A., et al. A comprehensive study of the neonatal manifestations of congenital dyserythropoietic anemia type I. J Pediatr Hematol Oncol 26 (2004) 746-748
80. Remacha A.F., Badell I., Pujol-Moix N., et al. Hydrops fetalis-associated dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation. Blood 100 (2002) 356-358
81. Li C.H., Lam C.W., Lee C.W., et al. Pearson's syndrome: a rare cause of non-immune hydrops fetalis. Chin Med J (Engl) 116 (2003) 1952-1954
82. Jacobs L.J., Jongbloed R.J., Wijburg F.A., et al. Pearson syndrome and the role of deletion dimmers and duplications in the mtDNA. J Inherit Metab Dis 27 (2004) 47-55
83. Knerr I., Metzler M., Niemeyer C.M., et al. Hematologic features and clinical course of an infant with Pearson syndrome caused by a novel deletion of mitochondrial DNA. J Pediatr Hematol Oncol 25 (2003) 948-951
84. Muis N., Beemer F.A., van Dijken P., et al. The Aase syndrome. Case report and review of the literature. Eur J Pediatr 145 (1986) 153-157
85. Auerbach A.D., and Wolman S.R. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 261 (1976) 494-496
86. Auerbach A.D. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 21 (1993) 731-733
87. German J., Schonberg S., Caskie S., et al. A test for Fanconi's anemia. Blood 69 (1987) 1637-1641
88. Taniguchi T., Garcia-Higuera I., Xu B., et al. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109 (2002) 459-472
89. MacMillan M.L., Auerbach A.D., Davies S.M., et al. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br J Haematol 109 (2000) 121-129
90. Grewal S.S., Kahn J.P., MacMillan M.L., et al. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 103 (2004) 1147-1151